Study of OTO-104 in Subjects With Unilateral Meniere’s Disease
Condition(s):Meniere’s DiseaseLast Updated:January 13, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Meniere’s DiseaseLast Updated:January 13, 2023Terminated
Condition(s):Relapsed Hematologic Malignancy; Refractory Hematologic MalignancyLast Updated:August 15, 2023Withdrawn
Condition(s):Meniere’s DiseaseLast Updated:December 14, 2022Terminated
Condition(s):Meniere’s DiseaseLast Updated:January 12, 2023Completed
Condition(s):Haematological MalignancyLast Updated:March 31, 2023Withdrawn
Condition(s):Autonomous Cortisol Secretion; Adrenal Incidentaloma; Non-functioning Adrenal AdenomasLast Updated:May 2, 2022Recruiting
Condition(s):LymphomaLast Updated:September 20, 2013Unknown status
Condition(s):HER2-positive Breast CancerLast Updated:January 3, 2024Active, not recruiting
Condition(s):COVID-19Last Updated:March 19, 2024Recruiting
Condition(s):OsteoarthritisLast Updated:January 11, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.